Drug effects on spermatogenesis

Drugs of Today

Volumn 43, Issue 10, 2007, Pages 717-724

  Amory, John K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANDROSTANOLONE; ANTIANDROGEN; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BICALUTAMIDE; CETRORELIX; CYCLOPHOSPHAMIDE; DUTASTERIDE; FINASTERIDE; FLUCONAZOLE; FLUTAMIDE; GANIRELIX; GONADORELIN DERIVATIVE; GONADOTROPIN; ITRACONAZOLE; KETOCONAZOLE; NEUROLEPTIC AGENT; NIFEDIPINE; NILUTAMIDE; OPIATE; PSYCHOTROPIC AGENT; SALAZOSULFAPYRIDINE; SPIRONOLACTONE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; UNINDEXED DRUG;

ALOPECIA; ARTHRITIS; AZOOSPERMIA; CHEMOTHERAPY; CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; EJACULATION; EJACULATION DISORDER; ENDOCRINE FUNCTION; ENDOMETRIOSIS; ENTERITIS; ENVIRONMENTAL EXPOSURE; ERECTILE DYSFUNCTION; FEMALE INFERTILITY; FERTILITY; GASTROESOPHAGEAL REFLUX; GYNECOMASTIA; HODGKIN DISEASE; HORMONE DEFICIENCY; HUMAN; HYPERTENSION; HYPOGONADISM; HYPOTHALAMIC PITUITARY GONADAL AXIS; IMPOTENCE; INFERTILITY; LIBIDO; LIFESTYLE; LOW DRUG DOSE; MALE FERTILITY; NONHUMAN; OLIGOSPERMIA; PROSTATE CANCER; PROSTATE HYPERTROPHY; RADIATION; REVIEW; SIDE EFFECT; SPERMATOGENESIS; SPERMATOZOON MOTILITY; TESTIS FUNCTION; TOBACCO; ULCERATIVE COLITIS;

FERTILITY; GONADS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFERTILITY, MALE; MALE; PHARMACEUTICAL PREPARATIONS; SPERMATOGENESIS; SPERMATOZOA; TESTIS;

EID: 36849045177     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2007.43.10.1131829     Document Type: Review

References (62)

1. Saunders, P.T. Germ cell-somatic cell interactions during spermatogenesis. Reprod Suppl 2003, 61: 91-101.
2. Amory, J.K., Bremner, W.J. Endocrine regulation of testicular function in men. Mol Cell Endocrinol 2001, 182(2): 175-9.
3. Guzick, D.S., Overstreet, J.W., Factor-Litvak P. et al. Sperm morphology, motility and concentration in fertile and infertile men. N Engl J Med 2001, 345(19): 1388-93.
4. WHO Laboratory Manual for the Examination of Human Semen and Sperm Cervical Mucous Interaction. (4th Ed). Cambridge University Press: Cambridge 1999.
5. Heckel, M.J. Production of oligospermia in a man by the use of testosterone propionate. Proc Soc Exp Biol Med 1939, 40: 658-9.
6. Matthiesson, K.L., McLachlan, R.I. Male hormonal contraception: Concept proven, product in sight? Hum Reprod Update 2006, 12(4): 463-82.
7. Handelsman, D.J. Testosterone: Use, misuse and abuse. Med J Aust 2006, 185(8): 436-9.
8. Liu, P.Y., Handelsman, D.J. The present and future state of hormonal treatment of male fertility. Hum Reprod Update 2003, 9(1): 9-23.
9. Kibble, M.W., Ross, M.B. Adverse effects of anabolic steroids in athletes. Clin Pharm 2001, 6(9): 686-92.
10. Turek, P.J., Williams, R.H., Gilbaugh, J.H. et al. The reversibility of anabolic steroid-induced azoospermia. J Urol 2001, 153(5): 1628-30.
11. Hayes, F.J., Seminara, S.B., Decruz, S., Boepple, P.A., Crowley, W.F. Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000, 85(9): 3027-35.
12. Hayes, F.J., Decruz, S., Seminara, S.B., Boepple, P.A., Crowley, W.F. Differential regulation of gonadotorpin secretion by testosterone in the human male: Absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001, 86(1): 53-8.
13. Guerin, J.F., Rollet, J. Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens. Int J Androl 1998, 11(3): 187-99.
14. Engel, J.B., Schally, A.V. Drug insight: Clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab 2007, 3(2): 157-67.
15. Finas, D., Hornung, D., Diedrich, K., Schultze-Mosgau, A. Cetrorelix in the treatment of female infertility and endometriosis. Expert Opin Pharmacother 2006, 7: 155-68.
16. Hadziselimovic, F., Senn, E., Bandhauer, K. Effect of treatment with chronic gonadotropin releasing hormone agonist on human testis. J Urol 1987, 138(4 Pt. 2): 1048-50.
17. Neumann, F. Effects of drugs and chemicals on spermatogenesis. Arch Toxicol Suppl 1984, 7: 109-17.
18. Wang, C., Lai, C.L., Lam, K.C., Yeung, K.K. Effect of cimitidine on gonadal function in man. Br J Clin Pharmacol 1982, 13(6): 791-4.
19. Williams, A.K. Gynecomastia: Breast enlargement in men, a rare adverse effect of spironolactone. Am J Nurs 2004, 104(11): 72AA-72GG.
20. Moayydei, P., Talley, N.J. Gastro-oesophageal reflux disease. Lancet 2006, 367: 2086-100.
21. Reyes, A.J., Leary, W.P., Crippa, G., Maranhao, M.R., Hernandez-Hernandez, R. The aldosterone antagonist and facultative diuretic eplerenone: A critical review. Eur J Intern Med 2005, 16(1): 3-11.
22. Smith, E.B., Henry, J.C. Ketoconazole: An orally effective antifungal agent. Mechanism of action, pharmacology, clinical efficacy and adverse effects. Pharmacotherapy 1984, 4(4): 199-204.
23. Marberger, M. Drug insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Nat Clin Pract Urol 2006, 3(9): 495-503.
24. Libecco, J.F., Bergfeld, W.F. Finasteride in the treatment of alopecia. Expert Opin Pharmacother 2004, 5(4): 933-40.
25. Overstreet, J.W., Fuh, V.L., Gould, J. et al. Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol 1999, 162(4): 1295-300.
26. Amory, J.K., Wang, C., Swerdloff, R. et al. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J Clin Endocrinol Metab 2007, 92(5): 1659-65.
27. Ragni, G., De Lauretis, L., Gambaro, V. et al. Semen evaluation in heroin and methadone addicts. Acta Eur Fertil 1985, 16(4): 245-9.
28. Singer, R., Ben-Bassat, M., Malik, Z. et al. Oligozoospermia, asthenozoospermia, and sperm abnormalities in ex-addict to heroin, morphine, and hashish. Arch Androl 1986, 16(2): 167-74.
29. Agirregoitia, E., Valdivia, A., Carracedo, A. et al. Expression and localization of delta-, kappa-, and mu-opiod receptors in human sper matozoa and implications for sperm motility. J Clin Endocrinol Metab 2006, 91(12): 4969-75.
30. Marken, P.A., Haykal, R.F., Fisher, J.N. Management of psychotropic-induced hyperprolactinemia. Clin Pharm 1992, 11: 851-6.
31. Henrick, V., Gitlin, M., Altshuler, L., Korenman, S. Antidepressant medications, mood and male fertility. Psychoneuroendocrinology 2000, 25: 37-51.
32. Howell, S.J., Shalet, S.M. Testicular function following chemotherapy. Hum Reprod Update 2001, 7(4): 363-9.
33. Howell, S.J., Shalet, S.M. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998, 27: 927-43.
34. Rivkess, S.A., Crawford. The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA 1989, 259: 2123-5.
35. Whitehead E, Shalet, S.M., Blackledge, G. et al. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 1982, 49(3): 418-22.
36. Viviani, S., Santoro, A., Ragni, G. et al. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs. ABVD. Eur J Cancer Clin Oncol 1985, 21(5): 601-5.
37. Meistrich, M.L., Parchuri, N., Wilson, G., Kurdoglu, B., Kangasniemi, M. Hormonal protection from cyclophosphamide-induced inactivation of rat stem spermatogonia. J Androl 1995, 16(4): 334-41.
38. Waxman, J.H., Ahmed, R., Smith, D. et al. Failure to preserved fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 1987, 19(2): 159-62.
39. Anger, J.T., Gilbert, B.R., Goldstein M. Cryopreservation of sperm: indications, methods and results. J Urol 2003, 170(4 Pt. 1): 1079-84.
40. Hershlag, A., Cooper, G.W., Benoff, S. Pregnancy following discontinuation of a calcium channel blocker in the male partner. Hum Reprod 1995, 10(3): 599-606.
41. Enders, G. Clinical approaches to male infertility with a case report of possible nifedipine-induced sperm dysfunction. J Am Board Fam Pract 1997, 10(2): 131-6.
42. Katsoff D, Check, J.K. A challenge to the concept that the use of calcium channel blockers causes reversible male infertility. Hum Reprod 1997, 12(7): 1480-2.
43. Levi, A.J., Fisher, A.M., Hughes, L., Hendry, W.E. Male infertility due to sulfasalazine. Lancet 1979, 2(8137): 276-8.
44. Toovey, S., Hudson, E., Hendry, W.F. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut 1981, 22(6): 445-51.
45. Toth, A. Reversible toxic effect of salicylazosulfapyridine on semen quality. Fertil Steril 1979, 31(5): 538-40.
46. Mijatovic, V., Hompes, P.G., Wouters, M.G.. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003, 108(2): 171-6.
47. Haimov-Kochman, R., Ben-Chetrit, E. The effect of colchicine treatment on sperm production and function: a review. Hum Reprod 1998, 13(2): 360-2.
48. Braunstein, G.D., Dahlgren, J., Loriaux, D.O. Hypogonadism in chronically lead poisoned men. Infertility 1978, 1: 33-5.
49. Lancranjan, I., Popiscu, H.I., Gavanescu, O. et al. Reproductive ability of workmen occupational exposed to lead. Arch Environ Health 1975, 30: 396-9.
50. Winder, C. Reproductive and chromosomal effects of occupational exposure to lead in males. Reprod Toxicol 1989, 3(4): 221-33.
51. Friberg, L., Piscator, M., Nordberg, G.F. et al. Cadmium in the Environment, 2nd Ed. CRC Press: Cleveland 1974, 37-53.
52. Weir, R.J., Fisher, R.S. Toxicological studies on borax and boric acid. Toxicol Appl Pharmacol 1972, 23: 351-64.
53. Wharton, M.D., Krauss, R.M., Marshall, S. Infertility in male pesticide workers. Lancet 1977, 2: 1259-61.
54. Lipschultz, L.T., Ross, E.C., Whorton, M.D. et al. DBCP and its effects on testicular function in man. J Urol 1980, 124: 464-8.
55. Lantz, G.D., Cunningham, G.R., Huckins, C., Lipshultz, L.I. Recovery from severe oligospermia after exposure to dibromochloroproane. Fertil Steril 1981, 35(1): 46-53.
56. Glass, R.I., Lyness, R.N., Mengle, D.C., Powell, K.E., Kahn, E. Sperm count depression in pesticide applicators exposed to dibromochloropropane. Am J Epidemiol 1979, 109(3): 346-51.
57. Muthusami, K.E., Chinnaswamy, P. Effect of chronic alcoholism on male fertility hormones and semen quality. Fertil Steril 2005, 84: 919-24.
58. Stutz, G., Zamudio, J., Santillan, M.E., Vincenti, L., de Cuneo, M.F., Ruiz, R.D. The effect of alcohol, tobacco, and aspirin consumption on seminal quality among healthy young men. Arch Environ Health 2004, 59: 548-52.
59. Hellstrom, W.J.G., Overstreet, J.W., Sikka, S.C. et al. Semen and sperm reference ranges for men 45 years of age and older. J Androl 2006, 27: 421-8.
60. Kunzole, R., Mueller, M.D., Hanggi, W. et al. Semen quality of male smokers and nonsmokers in infertile couples. Fertil Steril 2003, 79: 287-91.
61. Rossato, M., Ion Popa, F., Ferigo, M., Clari, G., Foresta, C. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab 2005, 90(2): 984-91.
62. Thompson, S.T. Prevention of male infertility: An update. Urol Clin North Am 1994, 21(3): 365-76.